Why 20+ Years to Approve a New Alzheimer’s Drug?

BREAKTHROUGH & TREATMENT: The new Alzheimer’s drug aducanumabab (Aduhelm) has received accelerated approval by the US Food and Drug Administration. Why did it take so long to get there?

Read more »

Back To Blog